{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:27:03Z","timestamp":1770445623024,"version":"3.49.0"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6526a2","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T15:51:50Z","timestamp":1468425110000},"page":"667-671","source":"Crossref","is-referenced-by-count":63,"title":["Trends in Methadone Distribution for Pain Treatment, Methadone Diversion, and Overdose Deaths \u2014 United States, 2002\u20132014"],"prefix":"10.15585","volume":"65","author":[{"given":"Christopher M.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant T.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Manocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica O.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin A.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R1","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief\u2014United States, 1999\u20132010.","volume":"61","author":"Paulozzi","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R2","unstructured":"Food and Drug Administration. Public health advisory: methadone use for pain control might result in death and life-threatening changes in breathing and heartbeat. Rockville, MD: Food and Drug Administration; 2006. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124346.htm"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R3","unstructured":"The Pew Charitable Trusts. Most states list deadly drug methadone as a \u201cpreferred drug.\u201d Philadelphia, PA: The Pew Charitable Trusts; 2015. http:\/\/www.pewtrusts.org\/en\/research-and-analysis\/blogs\/stateline\/2015\/4\/23\/most-states-list-deadly-methadone-as-a-preferred-drug"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R4","unstructured":"CDC. WONDER [Database]. Atlanta, GA: US Department of Health and Human Services, CDC; 2014. http:\/\/wonder.cdc.gov"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-160-1-201401070-00732","article-title":"Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.","volume":"160","author":"Nuckols","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R6","unstructured":"American Academy of Pain Medicine. The evidence against methadone as a \u201cpreferred\u201d analgesic. Chicago, IL: American Academy of Pain Medicine; 2014. http:\/\/www.painmed.org\/files\/the-evidence-against-methadone-as-a-preferred-analgesic.pdf"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R7","first-page":"563","article-title":"Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014United States, 2012.","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R8","unstructured":"Centers for Medicare & Medicaid Services. CMCS informational bulletin: best practices for addressing prescription opioid overdoses, misuse, and addiction. Baltimore, MD: US Department of Health and Human Services, Centers for Medicare & Medicaid Services; 2016. https:\/\/www.medicaid.gov\/federal-policy-guidance\/downloads\/cib-02-02-16.pdf"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm6526a2-201607131020-R10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jpain.2015.10.002","article-title":"The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy.","volume":"17","author":"Von Korff","year":"2016","journal-title":"J Pain"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:56:00Z","timestamp":1748998560000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6526a2.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":10,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2016,7,8]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6526a2","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7,8]]},"published":{"date-parts":[[2016,7,8]]}}}